Extract

The purpose of this study is to provide treatment for patients who have chronic lymphocytic leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide (FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of leukemia symptoms.

Inclusion criteria

• Chronic lymphocytic leukemia

Country

• Australia
• Belgium
• Canada
• Denmark
• France
• Hungary
• Italy
• Netherlands
• New Zealand
• Norway
• Poland
• Romania
• Russian Federation
• Spain
• Sweden
• United Kingdom
• United States

Links

• nct
• ictrp